Clinical Trials at University of Michigan Health System - Ann Arbor
As of September 2026, 12 paid clinical trials are recruiting at University of Michigan Health System - Ann Arbor, located at 401 EAST WASHINGTON STREET, 204A, ANN ARBOR, MI 48104, phone (734) 232-0112 in Ann Arbor, Michigan. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Advanced Solid Tumor and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
12 clinical trials at University of Michigan Health System - Ann Arbor
·Clear filters·A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Registry for Stage 2 Type 1 Diabetes
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Common conditions studied in Ann Arbor
- Malignant Solid Neoplasm (11 active studies)
- Advanced Solid Tumor (10 active studies)
- Heart Failure (10 active studies)
- Obesity (10 active studies)
- Stroke (10 active studies)
- Acute Myeloid Leukemia (9 active studies)
Leading research sponsors in Ann Arbor
- University of Michigan
- University of Michigan Rogel Cancer Center
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ann Arbor?
There are approximately 970 recruiting clinical trials in Ann Arbor, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ann Arbor pay participants?
Most recruiting trials in Ann Arbor compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ann Arbor?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ann Arbor?
The most common conditions under active study in Ann Arbor include Malignant Solid Neoplasm (11), Advanced Solid Tumor (10), Heart Failure (10), Obesity (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ann Arbor?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ann Arbor on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ann Arbor?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ann Arbor?
Recruiting research sites in Ann Arbor include University of Michigan, University of Michigan Rogel Cancer Center, Trinity Health Saint Joseph Mercy Hospital Ann Arbor, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ann Arbor right now?
The largest active categories in Ann Arbor are Cancer & tumors (278), Neurology & pain (75), Cardiovascular (62). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Michigan Health System - Ann Arbor?
University of Michigan Health System - Ann Arbor is located at 401 EAST WASHINGTON STREET, 204A, ANN ARBOR, MI 48104. Use the Google Maps link in the intro above to get directions.
How do I contact University of Michigan Health System - Ann Arbor?
You can reach University of Michigan Health System - Ann Arbor by phone at (734) 232-0112. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.